改良尿道括约肌的保护技术在双极等离子前列腺剜除术中的应用

卢振权; 袁渊; 罗兵锋; 朱逸飞; 侯健; 梁松武; 王铭池; 李佩丰; 罗光彦

doi:10.13201/j.issn.1001-1420.2021.08.010

改良尿道括约肌的保护技术在双极等离子前列腺剜除术中的应用

- 香港大学深圳医院泌尿外科(广东深圳, 518053)

详细信息

通讯作者: 袁渊,E-mail:yuany@hku-szh.org

中图分类号: R697

收稿日期: 2021-05-10

Retrospective analysis of the application of modified urethral sphincter protective technique in bipolar plasmakinetic enucleation of the prostate

- Department of Urology, The University of Hong Kong-Shenzhen Hospital, Shenzhen, Guangdong, 518053, China

More Information

Corresponding author: YUAN Yuan, E-mail: yuany@hku-szh.org

Received Date: 10 May 2021

摘要

摘要: 目的:探讨等离子前列腺电切术(PKRP)和改良尿道括约肌保护的双极等离子前列腺剜除术(PKEP)治疗良性前列腺增生(BPH)的疗效及对尿控功能的保护作用。方法:选取2020年6月—2021年3月我院泌尿外科诊断为BPH并行手术治疗的100例患者为研究对象并回顾性分析其临床数据。改良剜除组50例患者实施改良尿道括约肌保护的PKEP(颈部环切+顶部保留),等离子电切组50例患者实施PKRP。结果:两组患者术前一般资料比较,差异均无统计学意义(P＞0.05)。围术期相关资料行单因素分析发现改良剜除组手术时间长于等离子电切组[(120.4±34.9) min vs.(94.1±40.8) min,P＜0.01],而术中出血量少于等离子电切组[(86.2±44.6) mL vs.(166.1±152.1) mL,P＜0.01],差异有统计学意义。改良剜除组的术后QOL、术后Q_max及术后残余尿改善程度均优于等离子电切组,且差异有统计学意义(P＜0.01)。两组间术中并发症(P=0.22)、持续膀胱冲洗时间(P=0.15)、住院时间(P=0.39)、术后IPSS(P=1.00)、术后尿失禁发生率(P=0.24)的差异无统计学意义。结论:PKEP与PKRP相比具有更好的出血控制能力,更好的术后Q_max及残余尿改善程度,术后不增加尿失禁等并发症发生率,对于术后尿控功能具有一定的优势。
- 良性前列腺增生 /
- 等离子前列腺剜除术 /
- 等离子前列腺电切术 /
- 尿失禁
Abstract: Objective: To investigate the efficacy of plasmakinetic resection of prostate(PKRP) and modified urethral sphincter protective PKEP in the treatment of benign prostatic hyperplasia(BPH) and to compare the preservation of urine control function.Methods: A total of 100 patients with diagnosis of BPH and required surgery from June 2020 to March 2021 were selected and their clinical data were analyzed retrospectively. Fifty patients were treated with modified urethral sphincter protection of PKEP, while other 50 patients were treated with traditional PKRP.Results: There was no significant difference in preoperative general data between the two groups(P＞0.05). Univariate analysis of perioperative data showed that the operation time in the PKEP group was longer than that in the traditional plasma resection group [(120.4±34.9) min,(94.1±40.8) min, P＜0.01], but the intraoperative blood loss in the modified evisceration group was significantly lower than that in the traditional plasma resection group [(86.2±44.6) mL,(166.1±152.1) mL, P＜0.01]. The improvement of QOL in modified evisceration group was better than that in traditional plasma resection group(P＜0.01). The postoperative Q_max and residual urine were better in the modified evisceration group than in the traditional plasma resection group, and the difference was statistically significant(all P＜0.01). There was no significant difference in intraoperative complications(P=0.22), continuous bladder irrigation time(P=0.15), hospital stay(P=0.39), postoperative IPSS(P=1.00) or the incidence of postoperative urinary incontinence(P=0.24) between the two groups.Conclusion: Compared with the traditional plasma prostatectomy, the modified enucleation group has the advantages of better bleeding control, better improvement of postoperative maximum urinary flow rate and residual urine, rapid recovery and no increase in the incidence of urinary incontinence. It has certain advantages for postoperative urinary control function.
- benign prostatic hyperplasia /
- plasma enucleation of prostate /
- plasma electroresection of prostate /
- urinary incontinence

HTML全文

参考文献(22)

[1]	黄健,王建业,孔垂泽,等.中国泌尿外科和男科疾病诊断治疗指南:2019版[M].北京:科学出版社,2020:205.
[2]	Zhao Z,Zeng G,Zhong W,et al.A prospective,randomised trial comparing plasmakinetic enucleation to standard transurethral resection of the prostate for symptomatic benign prostatic hyperplasia:three-year follow-up results[J].Eur Urol,2010,58(5):752-758.
[3]	Oelke M,Bachmann A,Descazeaud A,et al.EAU Guidelines on the treatment and folow-up of non-neurogenicmale lower urinary tract symptoms including benign prostatic obstruction[J].Eur Urol,2013,64(1):118-140.
[4]	ElshalA,El-DemerdashY,MekkawyR,et al.V60 Plasmakinetic enucleation and resection of the prostate(PKERP)vs holmium laser enucleation of the prostate(HoLEP):Technical differences and short-term outcome[J].Eur Urol Suppl,2016,15(3):eV60.
[5]	刘俊峰,刘春晓,谭朝晖,等.经尿道双极等离子前列腺剜除术与电切术后尿失禁发生率的随机对照研究[J].中华男科学杂志,2014,20(2):165-168.
[6]	Yeo JK,Kim HJ.The authors reply:Korean clinical practice guideline for benign prostatic hyperplasia[J].Investig Clin Urol,2016,57(4):305.
[7]	El-Shaer W,Abou-Taleb A,Kandeel W.Transurethral bipolar plasmakinetic vapo-enucleation of the prostate:Is it safe for patients on chronic oral anticoagulants and/or platelet aggregation inhibitors?[J].Arab J Urol,2017,15(4):347-354.
[8]	谢铁军,任明华,郭鹏宇.半导体激光剜除术与等离子剜除术治疗良性前列腺增生有效性和安全性的Meta分析[J].哈尔滨医科大学学报,2020,54(4):450-455.
[9]	翁鸿,曾宪涛,任选义,等.经尿道等离子双极电切术与钬激光剜除术治疗良性前列腺增生症的系统评价[J].中国循证医学杂志,2018,18(8):840-849.
[10]	Chen SS,Lin MJ,Weng MF,et al.Influence of prostate size on the perioperative and postoperative outcome of transurethral plasmakinetic enucleation of the prostate:Results of 892 patients with 3 years of follow-up[J].Kaohsiung J Med Sci,2018,34(10):576-582.
[11]	Jiang Y,Bai X,Zhang X,et al.Comparative Study of the Effectiveness and Safety of Transurethral Bipolar Plasmakinetic Enucleation of the Prostate and Transurethral Bipolar Plasmakinetic Resection of the Prostate for Massive Benign Prostate Hyperplasia(＞80 ml)[J].Med Sci Monit,2020,26:e921272.
[12]	马明,龚彬彬,杨小荣,等.经尿道等离子剜除术与经尿道等离子电切术治疗良性前列腺增生的Meta分析[J].中国老年学杂志,2017,37(1):144-147.
[13]	Mitchell CR,Mynderse LA,Lightner DJ,et al.Efficacy of holmium laser enucleation of the prostate in patients with non-neurogenic impaired bladder contractility:results of a prospective trial[J].Urology,2014,83(2):428-432.
[14]	Krambeck AE,Handa SE,Lingeman JE.Experience with more than 1,000 holmium laser prostate enucleations for benign prostatic hyperplasia[J].J Urol,2013,189(1 Suppl):S141-S145.
[15]	Cornu JN,Ahyai S,Bachmann A,et al.A Systematic Review and Meta-analysis of Functional Outcomes and Complications Following Transurethral Procedures for Lower Urinary Tract Symptoms Resulting from Benign Prostatic Obstruction:An Update[J].Eur Urol,2015,67(6):1066-1096.
[16]	王政昊,白云金,张兴明,等.不同手术方式治疗大体积良性前列腺增生的有效性和安全性的网状Meta分析[J].中国循证医学杂志,2020,20(12):1413-1420.
[17]	刘春晓.经尿道前列腺解剖性剜除术的研究进展[J].微创医学,2015,10(3):263-268.
[18]	Liu C,Zheng S,Li H,et al.Transurethral enucleation and resection of prostate in patients with benign prostatic hyperplasia by plasma kinetics[J].J Urol,2010,184(6):2440-2445.
[19]	Sun T,Ma M,Chen W,et al.Transurethral Plasmakinetic enucleation of prostate versus Transurethral Plasmakinetic resection of prostate for benign prostate hyperplasia[J].Transl Androl Urol,2016,5(Suppl 1):AB016.
[20]	刘大乐,肖克峰,刘岩峰,等."四步法"保留膀胱颈等离子前列腺剜除术治疗前列腺增生的临床观察[J/OL].中华腔镜泌尿外科杂志(电子版),2020,14(2):124-128.
[21]	陈俊毅,陈东,王加良,等.经尿道前列腺等离予剜除术中保留尿控的策略[J].中华男科学杂志,2018,24(2):138-141.
[22]	Dalela D,Jeong W,Prasad MA,et al.A Pragmatic Randomized Controlled Trial Examining the Impact of the Retzius-sparing Approach on Early Urinary Continence Recovery After Robot-assisted Radical Prostatectomy[J].Eur Urol,2017,72(5):677-685.